Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 1
1981 1
1982 3
1983 3
1985 4
1986 1
1987 2
1989 3
1990 2
1991 2
1993 3
1994 2
1996 1
1997 1
1998 1
1999 2
2001 3
2002 5
2003 1
2004 6
2005 3
2006 3
2007 4
2008 4
2009 4
2010 3
2011 4
2012 3
2013 3
2014 4
2015 6
2016 5
2017 5
2018 5
2019 6
2020 5
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified"
Page 1
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R. Gupta S, et al. J Clin Oncol. 2018 Jun 1;36(16):1548-1555. doi: 10.1200/JCO.2017.75.9985. Epub 2018 Feb 12. J Clin Oncol. 2018. PMID: 29432076 Clinical Trial.
Purpose We compared the efficacy and toxicity of neoadjuvant chemotherapy followed by radical surgery versus standard cisplatin-based chemoradiation in patients with locally advanced squamous cervical cancer. Patients and Methods This was a single-center, phase III, …
Purpose We compared the efficacy and toxicity of neoadjuvant chemotherapy followed by radical surgery versus standard cisplatin-based chemor …
Cervical cancer.
Lea JS, Lin KY. Lea JS, et al. Obstet Gynecol Clin North Am. 2012 Jun;39(2):233-53. doi: 10.1016/j.ogc.2012.02.008. Epub 2012 Apr 24. Obstet Gynecol Clin North Am. 2012. PMID: 22640713
Squamous cell cervical cancer incidence and mortality have been reduced dramatically as a result of successful screening in many countries. ...Concurrent chemotherapy with radiation has been shown to have a survival advantage in patients with advanced-stage d …
Squamous cell cervical cancer incidence and mortality have been reduced dramatically as a result of successful screening in ma …
Management of Vaginal Cancer.
Shrivastava SB, Agrawal G, Mittal M, Mishra P. Shrivastava SB, et al. Rev Recent Clin Trials. 2015;10(4):289-97. doi: 10.2174/1574887110666150923112958. Rev Recent Clin Trials. 2015. PMID: 26411952 Review.
COMMENTS: Once spread from primary other cancers or vulva is ruled out, vaginal cancer is designated to be primary in origin. It was revealed that majority of vaginal cancers reported are squamous cell carcinomas. ...Preventive strategies include safe …
COMMENTS: Once spread from primary other cancers or vulva is ruled out, vaginal cancer is designated to be primary in origin. It was …
Staging for vaginal cancer.
Rajaram S, Maheshwari A, Srivastava A. Rajaram S, et al. Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):822-32. doi: 10.1016/j.bpobgyn.2015.01.006. Epub 2015 Mar 4. Best Pract Res Clin Obstet Gynaecol. 2015. PMID: 25847318 Review.
Primary vaginal cancer should be carefully assigned as spread from cervix, vulva, and other metastatic tumors to vagina can occur. ...Squamous cell carcinoma is still the most common histopathologic type followed by adenocarcinoma. ...
Primary vaginal cancer should be carefully assigned as spread from cervix, vulva, and other metastatic tumors to vagina can oc …
Cervical cancer in Pakistan: A review.
Batool SA, Sajjad S, Malik H. Batool SA, et al. J Pak Med Assoc. 2017 Jul;67(7):1074-1077. J Pak Med Assoc. 2017. PMID: 28770890 Review.
Cervix carcinoma is the second commonest condition in women under 50 years of age and third after breast and oral cavity cancers across all age groups. ...Our analysis indicated that infections associated with human papillomavirus posed the greatest risk of carcinoma …
Cervix carcinoma is the second commonest condition in women under 50 years of age and third after breast and oral cavity cancers acro …
Management of advanced primary urethral carcinomas.
Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Dayyani F, et al. BJU Int. 2014 Jul;114(1):25-31. doi: 10.1111/bju.12630. Epub 2014 May 22. BJU Int. 2014. PMID: 24447439 Review.
The sites and histology of urethral carcinoma vary by gender and anatomical location. Squamous cell carcinoma is most common among both genders but adenocarcinomas are noted in 15-35% of cases among women. ...In women, in addition to stage and location …
The sites and histology of urethral carcinoma vary by gender and anatomical location. Squamous cell carcinoma is …
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1).
Macchia G, Lancellotta V, Ferioli M, Casà C, Pezzulla D, Pappalardi B, Laliscia C, Ippolito E, Di Muzio J, Huscher A, Tortoreto F, Boccardi M, Lazzari R, Perrone AM, Raspagliesi F, Gadducci A, Garganese G, Fragomeni SM, Ferrandina G, Morganti AG, Gambacorta MA, Tagliaferri L. Macchia G, et al. Radiol Med. 2024 Jan;129(1):152-159. doi: 10.1007/s11547-023-01712-8. Epub 2023 Sep 12. Radiol Med. 2024. PMID: 37700153 Free PMC article.
BACKGROUND: Vulvar carcinoma is a rather uncommon gynecological malignancy affecting elderly women and the treatment of loco-regional advanced carcinoma of the vulva (LAVC) is a challenge for both gynecologic and radiation oncologists. ...The treatment interr …
BACKGROUND: Vulvar carcinoma is a rather uncommon gynecological malignancy affecting elderly women and the treatment of loco-regional …
Recurrent vulvar cancer.
Salom EM, Penalver M. Salom EM, et al. Curr Treat Options Oncol. 2002 Apr;3(2):143-53. doi: 10.1007/s11864-002-0060-x. Curr Treat Options Oncol. 2002. PMID: 12057077 Review.
With a central pelvic recurrence with antecedent radiotherapy involving the urethra, upper vagina, and rectum, total pelvic exenteration is indicated in a select group of patients with curative intent. Radiotherapy or chemoradiation concomitantly with wide radical local ex …
With a central pelvic recurrence with antecedent radiotherapy involving the urethra, upper vagina, and rectum, total pelvic exenterat …
Management and outcomes of primary vaginal Cancer.
Yang J, Delara R, Magrina J, Magtibay P, Langstraat C, Dinh T, Karlin N, Vora SA, Butler K. Yang J, et al. Gynecol Oncol. 2020 Nov;159(2):456-463. doi: 10.1016/j.ygyno.2020.08.036. Epub 2020 Sep 22. Gynecol Oncol. 2020. PMID: 32972784
OBJECTIVE: To analyze clinical characteristics and survival of patients with primary vaginal cancer. METHODS: Retrospective analysis of patients with primary squamous, adenocarcinoma and adenosquamous cell carcinoma of the vagina identified from …
OBJECTIVE: To analyze clinical characteristics and survival of patients with primary vaginal cancer. METHODS: Retrospective analysis …
Prognostic factors in patients with vulvar cancer: the VULCAN study.
Zapardiel I, Iacoponi S, Coronado PJ, Zalewski K, Chen F, Fotopoulou C, Dursun P, Kotsopoulos IC, Jach R, Buda A, Martinez-Serrano MJ, Grimm C, Fruscio R, Garcia E, Sznurkowski JJ, Ruiz C, Noya MC, Barazi D, Diez J, Diaz De la Noval B, Bartusevicius A, De Iaco P, Otero M, Diaz M, Haidopoulos D, Franco S, Blecharz P, Zuñiga MA, Rubio P, Gardella B, Papatheodorou DC, Yildirim Y, Fargas F, Macuks R; VULCAN Study coinvestigators. Zapardiel I, et al. Int J Gynecol Cancer. 2020 Sep;30(9):1285-1291. doi: 10.1136/ijgc-2019-000526. Epub 2020 Jun 22. Int J Gynecol Cancer. 2020. PMID: 32571891
Patients with intraepithelial neoplasia or primary treatment at non-participating centers were excluded. Global survival analysis and squamous cell histology subanalysis was performed. RESULTS: After excluding patients due to incomplete data entry, 1727 patients tre …
Patients with intraepithelial neoplasia or primary treatment at non-participating centers were excluded. Global survival analysis and squ …
114 results